Class action launched over alleged defects in pacemakers
A new proposed Canadian class action alleges that certain Boston Scientific pacemakers may pose serious health risks due to potential battery defects and device failures. On June 9, 2026, Siskinds Desmeules, Siskinds LLP’s Québec affiliate, filed an application in the Superior Court of Québe…
View the post titled Class action launched over alleged defects in pacemakersUnderstanding jurisdictional challenges in British Columbia class actions
Jurisdictional challenges are increasingly shaping the landscape of Canadian class actions, particularly in British Columbia. Two recent BC Court of Appeal decisions, Altria Group, Inc. v. Stephens, 2024 BCCA 99 (“Altria”) and NHK Spring Co., Ltd. v. Cheung, 2024 BCCA 236 (“NHK”) provide tim…
View the post titled Understanding jurisdictional challenges in British Columbia class actionsClass action pursued over infection risks linked to endoscope devices
A proposed Canadian class action has been commenced alleging that certain endoscope devices may expose patients to serious and potentially life-threatening infections. On April 13, 2026, Siskinds LLP’s Québec affiliate, Siskinds Desmeules, filed an application before the Superior Court of Qu…
View the post titled Class action pursued over infection risks linked to endoscope devicesParaquat (Gramoxone®) Parkinson’s class action certification upheld on appeal in British Columbia
Since 2021, Siskinds LLP has represented the plaintiffs in proposed paraquat (Gramoxone®) class actions across Canada, alleging that paraquat exposure is associated with an increased risk of developing Parkinson’s disease. These Canadian paraquat lawsuits allege that paraquat carries a serio…
View the post titled Paraquat (Gramoxone®) Parkinson’s class action certification upheld on appeal in British ColumbiaHow recent court rulings shape class action certification in British Columbia
If you are included in a class action that has been started in British Columbia, one of the first questions you likely have is whether the lawsuit will proceed. The answer depends on class action certification — a procedural step that determines whether a claim can move forward on behalf of …
View the post titled How recent court rulings shape class action certification in British ColumbiaClass action certification in British Columbia
Class actions are now a familiar part of the legal system in British Columbia. They allow people with similar legal claims to band together in a single lawsuit, making it possible to pursue cases that would be too expensive or complex to bring on an individual basis. In that sense, class act…
View the post titled Class action certification in British Columbia New consumer safeguards under British Columbia’s Business Practices and Consumer Protection Act
On March 31, 2025, British Columbia’s Bill 4 received Royal Assent, introducing several changes to the province’s Business Practices and Consumer Protection Act (the Act). Some of these amendments came into force immediately, while others will not be formally included in the Act until new re…
View the post titled New consumer safeguards under British Columbia’s Business Practices and Consumer Protection ActWhat British Columbia residents need to know about participating in class actions
As a Canadian, you have likely encountered news articles or other social media posts notifying you about ongoing or settled class actions. In recent years, you may have noticed that many of these class actions were commenced in British Columbia (BC). As a resident of British Columbia, you m…
View the post titled What British Columbia residents need to know about participating in class actionsClass action pursued concerning safety defects with GLP-1 drugs Mounjaro, Trulicity, & Zepbound
An application has been filed in Quebec to obtain authorization to institute a class action concerning the drugs Mounjaro, Trulicity, and Zepbound, alleging that the widely used diabetes and weight-loss medications may expose patients to serious health risks that were not adequately disclose…
View the post titled Class action pursued concerning safety defects with GLP-1 drugs Mounjaro, Trulicity, & ZepboundCancer-linked drug and product lawsuits: Legal pathways for affected patients
Patients who have been diagnosed with tumours or cancers after using pharmaceutical or health products may be able to pursue legal claims against manufacturers when credible scientific or regulatory evidence links those products to increased cancer risks. In such cases, product liability and…
View the post titled Cancer-linked drug and product lawsuits: Legal pathways for affected patientsReceive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.